Join GIBS Dean, Dr Morris Mthombeni in conversation with co-founder and the Group Chief Executive of the Aspen Group, Stephen Saad as they discuss his leadership, Aspen's strategic focus, the pharmaceutical industry, and recent developments around COVID-19 vaccine production and rollout.
Through the Group's recently completed sterile manufacturing capabilities, Aspen is now producing COVID vaccines currently aimed for global use with the majority of volumes destined for the African continent. Under Saad's leadership, Aspen also materially contributed to the management of the COVID-19 pandemic in 2020 through the global supply of anaesthetics and dexamethasone.
Date: Thursday, 8 June
Time: 14:00